This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent. Top assignees: Mayo Foundation for Medical Education and Research, University of Michigan, University of Pennsylvania. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2012
Title: Innovations by Goncalo Abecasis in Macular Degeneration
Introduction
Goncalo Abecasis is a prominent inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of medical research, particularly in the diagnosis and treatment of macular degeneration. His innovative work has the potential to impact many lives by improving the understanding and management of this condition.
Latest Patents
Goncalo Abecasis holds a patent titled "Compositions and methods for diagnosing and treating macular degeneration." This invention relates to biomarkers for macular degeneration, providing a plurality of biomarkers for monitoring and diagnosing the disease. The compositions and methods developed by Abecasis are applicable in diagnostic, therapeutic, research, and drug screening applications. He has 1 patent to his name.
Career Highlights
Throughout his career, Goncalo Abecasis has worked with esteemed institutions such as the Mayo Foundation for Medical Education and Research and the University of Michigan. His research has focused on advancing the understanding of genetic factors in diseases, particularly those affecting vision.
Collaborations
Goncalo Abecasis has collaborated with notable colleagues, including Wei Chen and Albert O Edwards. These partnerships have contributed to the advancement of research in the field of macular degeneration and other related areas.
Conclusion
Goncalo Abecasis is a key figure in the innovation of diagnostic methods for macular degeneration. His work continues to pave the way for future advancements in medical research and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile